| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $253 | — | — |
| R&D Expense | $62K | — | -37.2% |
| Operating Income | -$232K | — | +8.7% |
| Interest Expense | $11K | — | +11.2% |
| Income Tax | $0 | — | — |
| Net Income | -$243K | — | +11.2% |
| EPS (Diluted) | -$0.01 | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8K | -76.0% | +361.0% |
| Current Assets | $22K | -69.5% | +362.3% |
| Total Assets | $116K | -32.1% | +10.9% |
| Current Liabilities | $1.4M | +15.2% | -91.6% |
| Total Liabilities | $1.4M | +15.2% | -91.6% |
| Stockholders' Equity |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25K | — | +64.8% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $0 | — | -100.0% |
Business Overview
Eco Science Solutions, Inc. is a software company that provides cloud-based ERP and financial services platforms (Herbo and HerboPay) designed for regulated, cash-intensive industries. The company commenced limited revenue-generating activities through its HerboPay platform during the three months ended April 30, 2026, generating $253 in net revenue. In January 2026, the company completed significant debt settlement transactions through equity issuance, and subsequently executed a 1-for-25 reverse stock split effective May 4, 2026.
Segment Performance
The company operates as a single reporting segment. For the three months ended April 30, 2026 versus 2025: net revenue was $253 compared to $0; net operating loss was $232,229 versus $254,295; total operating expenses were $232,482 versus $254,295. Key expense components for 2026 versus 2025 included management and consulting fees of $122,500 versus $125,500, research/development/promotion of $62,033 versus $98,717, and legal/accounting/audit fees of $30,809 versus $17,459. Net loss per share was $(0.01) versus $(0.13).
Forward Guidance
Management intends to fund operations "through additional debt and equity financings, strategic transactions, improved operating performance and other capital raising initiatives." However, the company states "there can be no assurance that the Company will be successful in obtaining additional financing or achieving profitable operations." The company notes it "is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future."
Key Risk Factors
The company faces substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $69.5 million and a working capital deficit of $1.4 million as of April 30, 2026. The company has not generated significant revenues to date and is unlikely to generate significant earnings in the immediate or foreseeable future. Management's ability to obtain additional financing or achieve profitable operations remains uncertain, as does the company's dependence on strategic transactions and capital raising initiatives to fund operations.
| -$1.3M |
| -22.7% |
| +92.2% |